Rimon
 Save as PDF
RSS Feed Subscribe

New Quantum Holdings Announces Plans to Become Public in the USA

news New Quantum Holdings Announces Plans to Become Public in the USA Debbie A. Klis · New Quantum Holdings Announces Plans to Become Public in the USA Victoria Yang · New Quantum Holdings Announces Plans to Become Public in the USA Carl Sherer · New Quantum Holdings Announces Plans to Become Public in the USA Ivan Komaritsky · New Quantum Holdings Announces Plans to Become Public in the USA Craig Tanner · New Quantum Holdings Announces Plans to Become Public in the USA Robert (Bob) Cocchia · New Quantum Holdings Announces Plans to Become Public in the USA David Devernoe · New Quantum Holdings Announces Plans to Become Public in the USA Roy W. Gillig · New Quantum Holdings Announces Plans to Become Public in the USA Amy Baker · New Quantum Holdings Announces Plans to Become Public in the USA Anne Mitzelfelt · June 20, 2023

Rimon PC client, Canna-Global Acquisition Corp (“Canna-Global”) (NASDAQ:CNGL), a special purpose acquisition company, announced the signing of a definitive Bid Implementation and Business Acquisition Agreement with Sydney-based New Quantum Holdings Pty Ltd. (“New Quantum”), a provider of a vertically integrated technology and infrastructure offering for financial services firms, that will result in New Quantum becoming…

Continue Reading…

FDA Announces Pilot Program for Medical Device Submission with Health Canada but Spots Are Limited

insights FDA Announces Pilot Program for Medical Device Submission with Health Canada but Spots Are Limited Amy Baker · January 12, 2023

On January 10, 2023 the FDA announced that it has partnered with Health Canada to launch a joint eSTAR pilot. The pilot will allow medical device manufacturers to submit a premarket notice submission to FDA and Health Canada simultaneously. eSTAR initially debuted in 2020 for medical device submissions to FDA’s Center for Devices and Radiological…

Continue Reading…

Broadcast Retirement Network Interview: Classifying Aging as a Disease Could Speed FDA Drug Approvals

insights Broadcast Retirement Network Interview: Classifying Aging as a Disease Could Speed FDA Drug Approvals Amy Baker · January 9, 2023

Rimon attorney Amy Baker sat down with Jeffrey Snyder from the Broadcast Retirement Network to discuss the potential impact of classifying aging as a disease on FDA drug approvals. Watch the interview here. Find out more about the Broadcast Retirement Network here.   Amy Baker is a Partner in Rimon’s Orlando office. Ms. Baker focuses…

Continue Reading…

Classifying aging as a disease could speed FDA drug approvals

innovation Classifying aging as a disease could speed FDA drug approvals Amy Baker · Classifying aging as a disease could speed FDA drug approvals Mark H. Mirkin · Classifying aging as a disease could speed FDA drug approvals Steven Colby · Classifying aging as a disease could speed FDA drug approvals David Devernoe · January 3, 2023

Article originally published by The Hill. Republished with permission from publisher. Authored by Rimon attorney, Amy Baker. Attorneys Mark H. Mirkin, Steven Colby, JD, Ph.D. and David Devernoe contributed to the piece.  The Food and Drug Administration (FDA) considers aging to be a natural process. This makes it difficult to get FDA approval for drugs…

Continue Reading…

Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp.

news Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Debbie A. Klis · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Debra Vernon · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Ivan Komaritsky · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Victoria Yang · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Craig Tanner · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Amy Baker · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Roy W. Gillig · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Robert (Bob) Cocchia · Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp. Anne Mitzelfelt · December 8, 2022

Special purpose acquisition company, EDOC Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC”)  announced yesterday that it has entered into a definitive business combination agreement with Rimon client Australian Oilseeds Investments Pty. Ltd. Upon the satisfaction of all closing conditions, the transaction will result in Australian Oilseeds Holdings Limited, a to-be-formed Cayman Islands company, listing its…

Continue Reading…

The FTC is holding company executives personally accountable for data breaches as part of an aggressive effort to protect consumer data

insights The FTC is holding company executives personally accountable for data breaches as part of an aggressive effort to protect consumer data Amy Baker · November 9, 2022

The FTC is holding company executives personally accountable for data breaches as part of an aggressive effort to protect consumer data In a policy shift, the Federal Trade Commission (FTC) is targeting company executives in what it has described as “part of [its] aggressive efforts to ensure that companies are protecting consumers’ data and that…

Continue Reading…

Webinar: Intellectual Property Strategy for Innovative Companies – Patents, Copyrights, Trademarks and Other Considerations

events Webinar: Intellectual Property Strategy for Innovative Companies – Patents, Copyrights, Trademarks and Other Considerations Amy Baker · Webinar: Intellectual Property Strategy for Innovative Companies – Patents, Copyrights, Trademarks and Other Considerations David Devernoe · July 22, 2022

Intellectual Property Strategy for Innovative Companies – Patents, Copyrights, Trademarks and Other Considerations 4:00 PM – 5:00 PM EDT, July 26, 2022 For more information or to register, click here. Description:  Navigating the world of Intellectual Property (IP) can be daunting for innovative companies, but it can also be imperative to success. In this webinar,…

Continue Reading…

Global law firm Rimon PC adds Amy Baker as Life Sciences Partner and opens new office in Orlando

news Global law firm Rimon PC adds Amy Baker as Life Sciences Partner and opens new office in Orlando Amy Baker · May 31, 2022

Orlando, FL – Rimon, consistently recognized for its innovation and teamwork throughout its 46 offices is pleased to welcome life sciences attorney Amy Baker as a Partner in its new Orlando office.  Ms. Baker joins Rimon from Wilson Elser Moskowitz Edelman & Dicker LLP, where she was a Partner and co-chair of the firm’s life…

Continue Reading…